Search Results
Search results for "InterAx Biotech"
Results found for "InterAx Biotech"
- Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development
- Allosteric Binding Data Interpretation in Complex Receptor Systems
The data remains internally consistent, yet the interpretation fractures. The data remains internally consistent—but the inferred mechanism diverges from the underlying biology Kenakin highlights a multi-parameter framework in which different cooperativity factors govern interactions are defined by relational parameters, not absolute affinities Multiple cooperativity terms capture interactions Classical affinity models cannot capture these interactions because they lack the dimensionality required
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Surprisingly, this interaction did not result in G12 activation, even in the presence of GTP, which is This unproductive coupling revealed that non-cognate G protein interactions could modulate GPCR signalling This priming effect occurs through non-functional interactions between non-cognate G proteins and GPCRs It challenges the traditional view of strict cognate G protein coupling and suggests a more dynamic interaction This has significant implications for drug development, as targeting these non-cognate interactions could
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
Watch Episode 167 Today’s GPCR scientists don’t want to study one interaction, they want to model the three.” — Tom Sakmar A Use Case for Every Angle Beyond RAMPs, this platform can study: Scaffold protein interactions
- Radioligands vs. Fluorescent Ligands: Binding Assays
Understanding receptor-ligand interaction is key in drug discovery and biomedical research. ligands labeled with radioactive isotopes which can be used in binding assays to quantify other ligands’ interaction in the pharmacophore and its optimization ensure access to the binding site with minimal unspecific interactions Quantitative cell binding studies : Radioligands have superior precision when accounting for ligand-receptor interactions
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact as X-ray crystallography and cryo-electron microscopy, have successfully elucidated ligand-receptor interactions single method can fully capture the impact of residue alterations on ligand function and ligand-receptor interactions targeted (site-directed) approaches, mutagenesis can provide a comprehensive understanding of how drugs interact with different receptor regions and link these interactions to functional variations.
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company
- Decoding β-Arrestins: from Structure to function
changes, exposing an intracellular cavity (Kang, Y. et al. 2015, Chen, Q. et al. 2021), that allow interaction GPCR kinases (GRKs) and β-arrestins are activated by agonist-bound GPCRs and interact with the receptor . β-Arrestins facilitate this process by interacting with adapter protein 2 (AP-2) and clathrin. Consequently, understanding dynamic interactions between effectors during trafficking becomes crucial This approach reveals binding interfaces and interactions between GPCRs and β-arrestins, paving the way
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
The physical barrier this lipid bilayer creates is dynamic and interactive, becoming the foundation for many interactions involved in GPCR signaling6. via interaction with the adaptor protein 2 (AP2) and clathrin heavy chain mediating G protein-independent Transient interaction with the receptor catalyzes β-arrestin activation, including β-arrestin inter-domain Following dissociation from the receptor, the interaction of the extended finger loop with the lipid
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
These receptors respond to a variety of signals by undergoing structural changes that activate internal transitions of the Gs protein in complex with the β2-adrenergic receptor (β2AR) at brief sequential intervals This interaction significantly increases the receptor’s affinity for GTP, allowing a detailed observation of its interaction with the Gs protein in its activated state. This early interaction sets the stage for a cascade of significant conformational changes.
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
however, GPCRs are highly dynamic proteins and continuously adopt different conformations based on their interactions AlphaFold3, the latest version, has improved on this by modeling interactions with various compounds, It excels in modeling interactions with natural ligands but struggles to generalize this accuracy to
- Combined docking and machine learning identify key molecular determinants of ligand pharmacological
Ligands exert their action via the interactions in the ligand binding pocket. We hypothesized that there is a common set of receptor interactions made by ligands of diverse structures We used machine learning (ML) techniques to identify specific interactions that correlate with the agonist We demonstrate with the application of ML methods that it is possible to identify the key interactions The most representative interactions for agonist ligands involve K972.68Ă—67, F194ECL2, S2035.42Ă—43, S2045.43
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
provide new capabilities: -Â Â Â Â Â Â Â Â Â Â Â Real time tracking they allow continuous observation of GPCR interactions and following internalization and recycling upon activation. -Â Â Â Â Â Â Â Â Â Â Â High-throughput applications Bright and stable fluorescent ligands can be used in HTS, fast tracking the assessment of GPCR interactions These capabilities help with the quantification of functional receptor expression, following internalization , analyzing ligand-receptor interactions, which are not as detectable with antibodies.
- Fluorescence Polarization in GPCR Research
The ability to identify compounds that interact with molecular targets involved in disease pathways is This technique is most effective at studying interactions between large proteins and small ligands thanks Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists.
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
binding event that facilitates a change in the shape of a macromolecule which impacts a particular interaction amino acids from perturbations such as ligand binding, post-translational modification, or protein interactions binding to GPCRs can stabilise a distinct set of conformations, which promotes a certain pattern of interaction the conformational dynamics of the receptor rather than a lowered sensitivity for detecting weaker interactions Engineered mini-G proteins block the internalization of cognate GPCRs and disrupt downstream intracellular
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
In contrast, ligands like oxyntomodulin that preferentially activate ERK1/2 signaling interact more significantly For instance, the interaction of GLP-1 with ECL3, which leads to a tight conformation of the receptor's transmembrane domain (TM), contrasts with the looser interaction seen with biased agonists like exendin-P5 These agonists exhibit less interaction with ECL3, resulting in an open conformation of the TM6-ECL3- JAMA Internal Medicine, 2024. 184 (9): p. 1056-1064. 11. https://www.evaluate.com/thought-leadership/
- Diversification of PAR signaling through receptor crosstalk
receptors (PARs) are among the first receptors shown to transactivate other receptors: noticeably, these interactions In this review, we will focus on the evidence for PAR interactions with members of their own family, explore; from the signalling pathways triggered, to the physiological and pathological relevance of these interactions
- Do You Believe AI Could Accelerate Drug Discovery?
Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions development, such as the ability to tackle complex targets and accurately predict protein-molecule interactions Accurate structure prediction of biomolecular interactions with AlphaFold 3.
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
Moreover, molecular docking was applied to valid the important interactions between the ingredients and most significant pathways associated with depression treatment, including neuroactive ligand-receptor interaction in KXS, including Gomisin B, Asarone, Ginsenoside Rg1, Polygalaxanthone III and Pachymic acid, could interact ADRA, AR, ESR, NR3C1) and modulate the activation of multiple pathways (Neuroactive ligand -receptor interaction
- Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...
To interrogate the molecular mechanisms underlying this interaction, we conducted a host-directed CRISPR-Cas9 We identified pathways that have not been previously implicated in Hc interaction with macrophages, including leading to opsonization and release of small peptide fragments such as C3a, a role for C3aR in macrophage interactions Taken together, our results provide new insight into host processes that affect Hc-macrophage interactions
- Co-activation of GPCRs facilitate GIRK-dependent current
The present study examined the interaction between D2 and GABAB receptors using transient applications The heterologous facilitation was modelled based on the known cooperative interaction between the G protein The results suggest that the cooperative interaction between G βγ subunits and GIRK channels determines This study reports robust bidirectional interactions between these two converging receptor pathways.
- Diversity and specificity in location-based signaling outputs of neuronal GPCRs
it is becoming increasingly clear that GPCRs show great diversity in their intracellular location, interacting recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact
- Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs
Sakmar and Kotliar’s system is multiplexed and scalable , able to test hundreds of interactions from
- đź“° GPCR Weekly News - January 9 to 15, 2023
Cardiology, Endocrinology, and Taste Gender Differences in GRK2 in Cardiovascular Diseases and its Interactions Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions. SLAS2023 International Conference and Exhibition (February 25 - March 1). GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- Residency time of agonists does not affect the stability of GPCR-arrestin complexes
September 2022 "Background and purpose: The interaction of arrestins with G-protein coupled receptors (GPCRs) desensitizes agonist-dependent receptor responses and often leads to receptor internalization GPCRs that internalize without arrestin have been classified as "class A" GPCRs whereas "class B" GPCRs co-internalize with arrestin into endosomes. The interaction of arrestins with GPCRs requires both agonist activation and receptor phosphorylation
- đź“° GPCR Weekly News, July 3 to 9, 2023
Highly multiplexed bioactivity screening reveals human and microbiota metabolome-GPCRome interactions Structural and Molecular Insights into GPCR Function Dual mechanisms of cholesterol-GPCR interactions Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24
- Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling
Our analysis suggests that the structures of GPCRs bound to these interaction partners available today particular type of partner; (ii) subtle differences in the orientation of individual residues and/or their interactions
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational components of receptor-effector interactions remain incompletely described. We characterized the effects of extracellular loop mutations on agonist-promoted interactions of GPCRs Our studies reveal that F193 in extracellular loop 2 in the β2-adrenergic receptor mediates interactions












